Clinical trial
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With…
NCT00076687 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00076687 |
|---|---|
| Title | Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stroke, Muscle Spasticity, Motor Neuron Disease |
| Intervention type | Biological, Drug |
| Interventions | botulinum toxin Type A, saline |
| Enrollment | 155 |
| Start date | Oct 1, 2003 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Feb 26, 2004 |
| Last update posted | Oct 3, 2011 |
| Countries | Czechia, Hungary, Poland, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: